Angiogenesis: New Opportunities & Solutions for Drug Development
Venue: Hyatt Regency Cambridge
|Event Date/Time: Sep 29, 2003||End Date/Time: Sep 30, 2003|
"The Future of Therapeutics: From DNA to Angiogenesis"
James D. Watson
COLD SPRING HARBOR LABORATORIES
The therapeutic application of angiogenesis inhibitors has hit a major crossroad in development. After more than a decade of discovery and drug development, antiangiogenic agents have now shown efficacy in late stage clinical trials. This meeting will showcase both new and promising antiangiogenic therapeutic agents, present work on the current development of agents showing the greatest clinical potential, and discuss new challenges in successful drug development in this exciting field.
The Angiogenesis Clinic
The Angiogenesis Foundation
M.D. Anderson Cancer Center
National Institutes of Health
Sherris Pharma Partners
University of Oklahoma